INFU
InfuSystem Holdings, Inc
$9.70
+0.01 (+0.10%)
At close · Jul 8
Market Cap
$195.76M
Shares
20,181,703
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$143.44M
+6.4%
FY2025
Net Income
$6.63M
+182.6%
FY2025
Gross Margin
55.98%
+3.8pp
FY2025
Operating Margin
8.31%
+3.2pp
FY2025
Diluted EPS
$0.31
+181.8%
FY2025
Operating Cash Flow
$24.41M
+19.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $142.4M | $143.44M | $134.86M | $125.79M | $109.91M | $102.38M | $97.39M | $81.12M | $67.14M | $71.08M | $70.5M | $70.54M | $66.49M | $62.28M | $58.83M | $54.64M | $47.23M | $38.96M | |
| $29.99M | $30.36M | $28.56M | $27.05M | $24.49M | $21.68M | — | — | $56.58M | $61.09M | $62.21M | $62.95M | $58.72M | $55.96M | $53.47M | $46.8M | $43.38M | $38.61M | |
| $61.59M | $63.14M | $64.46M | $62.68M | $49.35M | $43.85M | $38.63M | $34.23M | $27.57M | $18.37M | $16.21M | $13.8M | $12.17M | $11.27M | $9.17M | $9.13M | $7.73M | $6.2M | |
| $80.81M | $80.3M | $70.4M | $63.11M | $60.56M | $58.54M | $58.76M | $46.88M | $39.57M | $43.36M | $44.74M | $49.6M | $47.35M | $43.68M | $42.91M | $35.36M | $33.55M | $28.64M | |
| — | 55.98% | 52.2% | 50.17% | 55.1% | 57.17% | 60.33% | 57.8% | 58.94% | 61.01% | 63.46% | 70.31% | 71.22% | 70.13% | 72.94% | 64.71% | 71.03% | 73.5% | |
| $10.58M | $10.49M | $11.31M | $12.65M | $12.26M | $10.78M | $9.66M | $9.93M | $9.11M | $9.78M | $9.66M | $10.42M | $9.75M | $9.66M | $9.86M | $9.37M | $7.09M | $5.26M | |
| $56.46M | $56.97M | $51.21M | $45.38M | $44.15M | $40.68M | $35.2M | $28.99M | $25.4M | $25.23M | $24.63M | $23.78M | $19.99M | $18.97M | $23.06M | $17.99M | $20.62M | $12.22M | |
| $881K | $920K | $991K | $990K | $2.49M | $4.26M | $4.29M | $4.4M | $4.65M | $5.56M | $3.85M | $2.88M | $2.52M | $2.62M | $2.73M | $2.66M | $2.26M | $1.83M | |
| $13.23M | $13.29M | $12.5M | $12.51M | $13.36M | $14.63M | $14.03M | $12.34M | $11.31M | — | — | — | — | — | — | — | — | — | |
| $67.92M | $68.38M | $63.51M | $59.02M | $58.91M | $55.72M | $49.93M | $43.36M | $39.16M | $47.17M | $43.77M | $42.32M | $38.02M | $37.78M | $40.91M | $101.71M | $34.48M | $23.31M | |
| $12.89M | $11.92M | $6.89M | $4.09M | $1.65M | $2.82M | $8.83M | $3.53M | $415K | -$3.81M | $974K | $7.28M | $9.33M | $5.9M | $2M | -$66.36M | -$938K | $5.33M | |
| — | 8.31% | 5.11% | 3.25% | 1.5% | 2.75% | 9.06% | 4.35% | 0.62% | -5.36% | 1.38% | 10.32% | 14.03% | 9.47% | 3.4% | -121.45% | -1.99% | 13.67% | |
| $26.12M | $25.21M | $19.39M | $16.6M | $15.01M | $17.45M | $22.85M | $15.87M | $11.72M | — | — | — | — | — | — | — | — | — | |
| $1.22M | $1.3M | $1.78M | $2.17M | $1.4M | $1.38M | $1.26M | $1.9M | $1.42M | $1.33M | $1.34M | $1.71M | $3.13M | $3.5M | $3.34M | $2.19M | $3.35M | $3.5M | |
| $113K | $2000 | -$55K | -$67K | -$122K | -$186K | -$29K | -$97K | -$1.46M | -$1.45M | -$1.34M | -$3.29M | -$3.12M | -$3.2M | -$4.15M | -$2.22M | -$2.29M | -$3.58M | |
| $11.79M | $10.62M | $5.06M | $1.85M | $130K | $1.26M | $7.54M | $1.52M | -$1.04M | -$5.26M | -$364K | $3.99M | $6.21M | $2.7M | -$2.15M | -$68.58M | -$3.22M | $1.75M | |
| $3.88M | $4M | $2.71M | $979K | $112K | -$163K | -$9.79M | $163K | $53K | $15.45M | -$142K | $1.2M | $2.85M | $1.03M | -$663K | -$23.13M | -$1.37M | $977K | |
| $7.91M | $6.63M | $2.35M | $872K | $18K | $1.42M | $17.33M | $1.36M | -$1.1M | -$20.71M | -$222K | $2.79M | $3.36M | $1.67M | -$1.49M | -$45.44M | -$1.85M | $774K | |
| — | 4.62% | 1.74% | 0.69% | 0.02% | 1.39% | 17.8% | 1.68% | -1.63% | -29.13% | -0.31% | 3.95% | 5.05% | 2.68% | -2.53% | -83.17% | -3.92% | 1.99% | |
| $7.62M | $6.07M | $2.38M | $471K | $1.24M | $1.69M | $17.33M | $1.36M | — | — | — | — | — | $1.67M | -$1.35M | -$45.52M | -$1.92M | — | |
| USD/shares | — | $0.32 | $0.11 | $0.04 | $0.00 | $0.07 | $0.86 | $0.07 | -$0.05 | -$0.91 | -$0.01 | $0.13 | $0.15 | $0.08 | -$0.07 | -$2.16 | -$0.09 | $0.04 |
| USD/shares | — | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 | $0.80 | $0.07 | -$0.05 | -$0.91 | -$0.01 | $0.12 | $0.15 | $0.08 | -$0.07 | -$2.16 | -$0.09 | $0.04 |
| shares | — | 20.66M | 21.27M | 21.02M | 20.65M | 20.52M | 20.11M | 19.73M | 21.42M | 22.74M | 22.62M | 22.41M | 22.15M | 21.87M | 21.43M | 21.07M | 19.72M | 18.61M |
| shares | — | 21.1M | 21.71M | 21.65M | 21.55M | 22.05M | 21.72M | 20.84M | 21.42M | 22.74M | 22.62M | 22.84M | 22.55M | 22.07M | 21.43M | 21.07M | 19.72M | 18.93M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2025: $28.73M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 3.70×
EV/EBIT
—
Medical Devices median 21.44×
P/E (TTM)
26.22×
Medical Devices median 26.54×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Patient Services and Device Solutions | $113,080,000 | $106,301,000 | $98,737,000 | $85,429,000 | $80,704,000 | — | — |
| Patient Services | $86,532,000 | $80,378,000 | $76,541,000 | $68,881,000 | $65,598,000 | — | — |
| Device Solutions | $64,096,000 | $61,737,000 | $55,825,000 | $47,506,000 | $42,537,000 | — | — |
| DME Services Segment | — | — | — | $47,506,000 | $42,537,000 | $41,686,000 | $33,363,000 |
| ITS Segment | — | — | — | $68,881,000 | $65,598,000 | $61,072,000 | $51,540,000 |
By Product & Service (USD)
| Component | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Third Party Payer Rental | $52,847,000 | $49,266,000 | $40,510,000 |
| Direct Payer Rentals | $29,302,000 | $28,525,000 | $24,116,000 |
| Product | $15,514,000 | $17,357,000 | $14,336,000 |
| Service | $4,719,000 | $2,240,000 | $2,153,000 |